Redmile Group, LLC Aurinia Pharmaceuticals Inc. Transaction History

Redmile Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$6.05 - $6.75 $1.96 Million - $2.18 Million	-323,265 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$6.06 - $7.64 $1.96 Million - $2.47 Million	323,265 New	323,265 $2.1 Million
Q4 2017 Feb 14, 2018	SELL	$4.53 - $7.09 $1.51 Million - $2.36 Million	-332,310 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$5.71 - $6.9 $1.9 Million - $2.29 Million	332,310	332,310 $2.08 Million

227

58.9M

949K

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.16B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmile Group, LLC with notifications on news.